Antonio R. Pera, a director at ANI Pharmaceuticals ($ANIP), made two open market sales of common shares in the last year, totaling about $1.18 million. His most recent sale occurred on September 3, 2025. These sales rank 4,550th among 11,678 individual insiders, where the average is $8.6 million across roughly 6.4 transactions per insider. Pera made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 3, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Pera Antonio R | Director | S | Common Stock | 7292 | $94.94 | 22,660.0000 | 22,322,000 | 24.35% | 0.03% |
| Aug. 20, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Pera Antonio R | Director | S | Common Stock | 5421 | $89.73 | 29,952.0000 | 22,322,000 | 15.33% | 0.02% |
| May 22, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Pera Antonio R | Director | A | Common Stock | 4336 | $0.00 | 35,373.0000 | 21,538,000 | 13.97% | 0.02% |
| May 21, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Pera Antonio R | Director | A | Common Stock | 4410 | $0.00 | 31,037.0000 | 20,731,000 | 16.56% | 0.02% |
| March 4, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Pera Antonio R | Director | S | Common Stock | 7000 | $65.20 | 26,627.0000 | 20,731,000 | 20.82% | 0.03% |
| Aug. 14, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Pera Antonio R | Director | S | Common Stock | 3000 | $60.37 | 33,627.0000 | 17,644,000 | 8.19% | 0.02% |
| May 23, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Pera Antonio R | Director | A | Common Stock | 6865 | $0.00 | 36,627.0000 | 17,644,000 | 23.07% | 0.04% |